Abcellera Biologics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $29M | 8.5M | 3.43 |
| 2025-03-31 | $35M | 16M | 2.23 |
| 2024-12-31 | $13M | 4.5M | 2.93 |
| 2024-09-30 | $12M | 4.6M | 2.60 |
| 2024-06-30 | $14M | 4.6M | 2.96 |
| 2022-06-30 | $341k | 32k | 10.65 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas